The Aperlena Verdict
Open raceNo supplier dominates: 68 different companies have won the last 106 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 106 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis public procurement covers the supply of medicinal products for parenteral administration containing the active substance eculizumab (ATC code L04AJ01). The products are intended for the treatment of patients in indications approved according to the Summary of Product Characteristics (SmPC) valid on the date of submission of tenders. The procurement concerns selective immunosuppressants administered intravenously, and the subject matter is defined by reference to the authorised indications rather than by named quantities. No lots, volumes, duration or place of delivery are specified in the notice text, so bidders should consult the full notice documents for all further technical and commercial requirements before preparing an offer.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 10 hours ago
More from this buyer
Full buyer profile33 open tenders right now
- Building modifications of the transplant ICU on the 1st floor of Building E 5 days left
- Czech Republic - Syringes - Supplies of disposable two-part syringes 5 days left
- Renal consumables - Supplies of dialysis sets and related consumables for haemodialysis machines 7 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Medtronic Czechia s.r.o. | 7 | €11.4M | Jul 2026 |
| Alliance Healthcare s.r.o. | 5 | €8.7M | Jul 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 4 | €9.0M | Aug 2026 |
| ADYTON s.r.o., (angl. Ltd, něm. GmbH, franc. S.R.L.A.) | 4 | €3.0M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 3 | €21.1M | May 2026 |
Based on 106 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 107 comparable contracts this buyer awarded in this sector over the last 4 years.
- €248,636
- Lower quartile
- €628,512
- Median award
- €1.8M
- Upper quartile
This tender is estimated 406% above that median
Most recent awards
- Česko - Imunoglobuliny - Imunoglobuliny IVIG VI. €2,415,872
- Czech Republic - Corticosteroids for systemic use - Corticosteroids for systemic use III. €196,270
- Česko - Imunosupresiva - Selektivní imunosupresiva - inhibitory Janus kináz II. - Upadacitinib €2,920,849
- Česko - Diagnostika - DG - Dodávka reagencií k multiplexní detekci respiračních patogenů s výpůjčkou přístroje I. €141,873
- Czech Republic - Echocardiograph - Echocardiograph for the KTOP €169,635
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
3
days left
€290,468
est. value
3
days left
€674,542
est. value
3
days left
€5,736,062
est. value
3
days left
€1,254,163
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,113,906
- Buyer track record on Aperlena
- 366 notices tracked · 171 awarded
- €291,897,214 in awarded contracts
Never miss a tender like this
177 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert